Shanghai Benemae’s Benaglutide Approved by NMPA for Adult Weight Management in China
The National Medical Products Administration (NMPA) has indicated on its website that benaglutide, developed by...
Nanjing Leads Biolabs’ LBL-034 Secures Clinical Trial Approvals from NMPA and FDA
Nanjing Leads Biolabs Co., Ltd, a China-based biopharmaceutical company, has announced receiving clinical trial approvals...
Sanofi to Boost CHC Unit with Full Acquisition of US Health Brand Qunol
France-based pharmaceutical giant Sanofi (NASDAQ: SNY) has revealed that it has signed an agreement to...
AstraZeneca’s Alexion Secures Gene Therapy Portfolio in Deal with Pfizer
AstraZeneca’s rare disease unit, Alexion (AZ, NASDAQ: AZN), has signed a significant purchase and license...
AstraZeneca’s H1 2023 Financials Show 4% YOY Revenue Growth, Oncology and R&I Drive Sales
UK-based pharmaceutical giant AstraZeneca plc (AZ, NASDAQ: AZN) has announced its financial results for the...
Sanofi Reports 3.3% YOY Sales Growth in Q2 2023, Driven by Vaccines and Dupixent
France-based Sanofi (NASDAQ: SNY) has released its financial results for the second quarter of 2023,...
Huadong Medicine Receives NMPA Approval for Phase I Clinical Trial of DR10624 for Weight Management
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced that it has received approval from...
NMPA Seeks Public Input on Strengthening Supervision of Medical Device Contract Manufacturing
The National Medical Products Administration (NMPA) is currently seeking public feedback on the “Opinions on...
China’s NHC Launches Trial Specifications for Clinical Decision Support Systems in Hospitals
The National Health Commission (NHC) has issued a set of specifications for the application and...
NHSA Issues 2023 Guidelines: Enhancing Basic Medical Insurance and Major Illness Coverage
The National Healthcare Security Administration (NHSA) has released the “Notice on Ensuring Basic Healthcare Security...
Akeso Biopharma Initiates Phase Ia/Ib Study for TIGIT mAb AK127 in Solid Tumors Combination Therapy
China-based Akeso Biopharma (HKG: 9926) has announced the first patient enrollment in a Phase Ia/Ib...
ACROBiosystems Partners with OBiO Technology to Advance Cell and Gene Therapy
ACROBiosystems Group (SHE: 301080) has announced a partnership with China-based gene therapy specialist OBiO Technology...
Lucence and Innovent Biologics Partner to Enhance Access to Cholangiocarcinoma Treatment in Hong Kong
Singapore-based precision medicine specialist Lucence, with a presence in Suzhou, Hong Kong, and Palo Alto...
Beijing Balance Medical’s Transcatheter Valve System Enters China’s Innovative Device Review
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that its transcatheter valve...
Eli Lilly’s Tirzepatide Demonstrates Up to 26.6% Weight Loss in Phase III Obesity Studies
US pharmaceutical major Eli Lilly & Co., (NYSE: LLY) has released final results from two...
CDE Issues Guiding Principles for Natural History Research in Rare Disease Drug Development
The Center for Drug Evaluation (CDE) has released the “Guiding Principles for Natural History Research...
Sino Biopharmaceutical Receives NMPA Approval for Biosimilar Herceptin for HER2+ Cancers
Sino Biopharmaceutical Ltd (HKG: 1177) has announced that it has received market approval from the...
CDE Launches Technical Guidelines to Emphasize Patient-Centered Drug Clinical Trials
The Center for Drug Evaluation (CDE) has released a series of Technical Guidelines that encompass...
Eli Lilly’s Donanemab Shows Significant Slowdown in Alzheimer’s Disease Progression in Phase III Study
US pharmaceutical major Eli Lilly and Company (NYSE: LLY) has revealed the complete results of...